openPR Logo
Press release

From Tech Burnout to Total Health: Dr. James Lovinsky Leads a New Wave of Integrative Medicine in Rhode Island

10-24-2025 09:20 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

From Tech Burnout to Total Health: Dr. James Lovinsky Leads a New

Opus Total Health helps patients heal chronic pain, stress, and gut issues through acupuncture, functional medicine, and holistic care.
Image: https://www.abnewswire.com/upload/2025/10/03097c743fc4ab74c45ba5a60aafa58d.jpg

West Greenwich, RI - What happens when technology, stress, and chronic pain push someone to their breaking point? For Dr. James Lovinsky, it sparked a complete life transformation-and a thriving integrative wellness practice that's helping Rhode Islanders reclaim their health.

Dr. Lovinsky, founder of Opus Total Health in West Greenwich, left a career in web development after years of battling chronic pain, headaches, and burnout. When traditional medicine failed to offer lasting relief, he turned to acupuncture-and the results changed his life.

"Acupuncture was the first thing that helped me truly heal, not just mask the symptoms," says Dr. Lovinsky. "I knew I wanted to help others who feel stuck and out of options-because I've been there myself."

Today, Opus Total Health has become one of Rhode Island's most respected integrative care clinics, combining acupuncture, herbal therapy, functional medicine, massage therapy, and nutrition under one roof. With over 50 years of combined practitioner experience, the Opus team works together to treat the root causes of pain, stress, hormonal imbalance, and gut health issues.

At the heart of their approach is a simple philosophy: "You're not broken-and you will get better."

Patients come to Opus Total Health from across New England seeking natural, evidence-informed solutions for conditions such as:

*
Chronic pain (back, knee, shoulder, neck, and sciatica)

*
Digestive disorders (GERD, IBS, Crohn's, bloating)

*
Stress, anxiety, and sleep issues

*
Injury recovery and post-surgery support

Unlike conventional care, Opus Total Health offers personalized, multi-modal treatment plans that blend ancient Chinese medicine with modern diagnostic tools and nutrition science.

"People want to feel heard," Dr. Lovinsky explains. "We spend time with our patients, understand their story, and build a plan that helps them take charge of their health."

In addition to Dr. Lovinsky, the clinic's team includes his wife and fellow Doctor of Acupuncture, Dr. Linnea Snyder Lovinsky (DAOM), and other specialists who provide a holistic, team-based experience for each client.

The practice is now expanding its community outreach, collaborating with local wellness organizations and appearing on health and lifestyle podcasts to educate the public about natural pain relief, integrative wellness, and the mind-body connection.

For those struggling with chronic pain or health issues that "no one can figure out," Dr. Lovinsky offers a message of hope:

"You don't have to settle for feeling unwell. With the right approach, healing is absolutely possible."

About Opus Total Health

Located in West Greenwich, Rhode Island, Opus Total Health is a multidisciplinary clinic offering acupuncture, naturopathic medicine, massage therapy, nutrition counseling, and functional medicine. Founded by Dr. James Lovinsky (DACM, L.Ac.), the clinic's mission is to help patients find lasting relief and balance through evidence-informed, personalized care.

For more information or to book an appointment, visit www.opustotalhealth.com [https://opustotalhealth.com?utm_source=chatgpt.com] or call (401) 397-6333.

For interviews, podcast appearances, or speaking opportunities with Dr. James Lovinsky, please contact: media@opustotalhealth.com or call (401) 397-6333

Media Contact
Company Name: Opus Total Health
Contact Person: Dr. James Lovinsky
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=from-tech-burnout-to-total-health-dr-james-lovinsky-leads-a-new-wave-of-integrative-medicine-in-rhode-island]
City: West Greenwich
State: RI
Country: United States
Website: http://www.opustotalhealth.com

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release From Tech Burnout to Total Health: Dr. James Lovinsky Leads a New Wave of Integrative Medicine in Rhode Island here

News-ID: 4238669 • Views:

More Releases from ABNewswire

Active Implantable Medical Devices Market Is Expected to Reach USD 44,906.36 million by 2032 | DelveInsight
Active Implantable Medical Devices Market Is Expected to Reach USD 44,906.36 mil …
The leading companies operating in the active implantable medical devices market include Medtronic, Johnson and Johnson Services, Inc., Abbott, Boston Scientific Corporation, LivaNova PLC., Axonics, Inc., Aleva Neurotherapeutics, Sonova Holding AG, Bioventus Inc., CARMAT, Jarvik Heart Inc., BIOTRONIK SE & Co. KG, MicroTransponder Inc., MED-EL Medical Electronics, NeuroPace, Inc., NEVRO CORP., Shree Pacetronix, Cochlear Ltd., Berlin Heart, Blackrock Neurotech, and others. DelveInsight's "Active Implantable Medical Devices Market Insights, Competitive Landscape, and
Global Heparin Market Poised to Reach USD 18.19 Billion by 2032, Driven by Rising Cardiovascular Disorders and Cancer Prevalence, States DelveInsight
Global Heparin Market Poised to Reach USD 18.19 Billion by 2032, Driven by Risin …
Major players shaping the global heparin market include Pfizer Inc., Dr. Reddy's Laboratories Ltd., Gland Pharma Limited, Sanofi, B. Braun Melsungen AG, Fresenius SE & Co. KGaA, Novartis AG, Baxter, Leo Pharma A/S, and Cardinal Health. Continuous investments in R&D, formulation improvements, mergers, and global distribution partnerships remain vital elements of their growth strategy. DelveInsight's "Heparin Market Insights, Competitive Landscape, and Market Forecast - 2032" report delivers a comprehensive analysis of
Global Phage Therapy Pipeline Accelerates as 20+ Biotech Companies Advance Next-Generation Antibacterial Treatments | DelveInsight
Global Phage Therapy Pipeline Accelerates as 20+ Biotech Companies Advance Next- …
Key phage therapy companies such as Locus Biosciences, Armata Pharmaceuticals, BiomX, SNIPR Biome, Phagelux, PHAXIAM Therapeutics, Phico Therapeutics, Technophage, and others. DelveInsight's 'Phage Therapies Competitive Landscape 2025' report provides comprehensive global coverage of pipeline phage therapies in various stages of clinical development, major pharmaceutical companies are working to advance the pipeline space and future growth potential of the phage therapies pipeline domain. The phage therapy market is witnessing robust growth driven by
Systemic Juvenile Idiopathic Arthritis Market Analysis 2034 - Competitive Landscape, Clinical Trials, Market Share, Therapies, Prevalence, and Key Players by DelveInsight
Systemic Juvenile Idiopathic Arthritis Market Analysis 2034 - Competitive Landsc …
Systemic Juvenile Idiopathic Arthritis Companies are Chugai Pharmaceutical, AstraZeneca, Pfizer, Incyte Corporation Novartis, Roche, Genentech, AbbVie, Pfizer, Eli Lilly and Company, Bristol Myers Squibb, Johnson & Johnson, Merck & Co., UCB, Sanofi, and others. DelveInsight's "Systemic Juvenile Idiopathic Arthritis Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of Systemic Juvenile Idiopathic Arthritis, historical and forecasted epidemiology as well as the Systemic Juvenile Idiopathic Arthritis market trends in the

All 5 Releases